Suvretta Capital Management Has Raised Its Jd Com (JD) Position; Last Week Genomic Health, Inc. (GHDX) Coverage

December 14, 2017 - By Neil V. Hobbs

Among 10 analysts covering Genomic Health (NASDAQ:GHDX), 3 have Buy rating, 3 Sell and 4 Hold. Therefore 30% are positive. Genomic Health had 27 analyst reports since August 5, 2015 according to SRatingsIntel. The stock of Genomic Health, Inc. (NASDAQ:GHDX) has “Hold” rating given on Monday, June 12 by Jefferies. Jefferies maintained the shares of GHDX in report on Tuesday, September 12 with “Hold” rating. The stock of Genomic Health, Inc. (NASDAQ:GHDX) earned “Buy” rating by Canaccord Genuity on Monday, August 14. On Wednesday, January 6 the stock rating was upgraded by Canaccord Genuity to “Buy”. The stock of Genomic Health, Inc. (NASDAQ:GHDX) has “Underweight” rating given on Wednesday, September 2 by Barclays Capital. As per Wednesday, August 17, the company rating was maintained by Jefferies. The stock has “Neutral” rating by Piper Jaffray on Monday, January 11. As per Wednesday, November 15, the company rating was maintained by Canaccord Genuity. On Friday, August 28 the stock rating was upgraded by Raymond James to “Market Perform”. The company was upgraded on Monday, November 23 by UBS. See Genomic Health, Inc. (NASDAQ:GHDX) latest ratings:

13/12/2017 Broker: J.P. Morgan Rating: Sell New Target: $25.0 Downgrade
13/12/2017 Broker: JP Morgan Old Rating: Neutral New Rating: Underweight Downgrade
15/11/2017 Broker: Canaccord Genuity Rating: Buy New Target: $39.0 Maintain
20/10/2017 Broker: Jefferies Rating: Hold New Target: $34.0 Maintain
25/09/2017 Broker: Canaccord Genuity Rating: Buy New Target: $35.0 Maintain
12/09/2017 Broker: Jefferies Rating: Hold New Target: $33.0 Maintain
14/08/2017 Broker: Canaccord Genuity Rating: Buy New Target: $35.0000 Maintain

Suvretta Capital Management Llc increased Jd Com Inc (JD) stake by 18.41% reported in 2017Q2 SEC filing. Suvretta Capital Management Llc acquired 555,990 shares as Jd Com Inc (JD)’s stock rose 37.55%. The Suvretta Capital Management Llc holds 3.58 million shares with $140.28M value, up from 3.02M last quarter. Jd Com Inc now has $57.63B valuation. The stock decreased 0.81% or $0.33 during the last trading session, reaching $40.47. About 15.52M shares traded. JD.com, Inc. (NASDAQ:JD) has risen 77.67% since December 14, 2016 and is uptrending. It has outperformed by 60.97% the S&P500.

Among 21 analysts covering JD.com (NASDAQ:JD), 16 have Buy rating, 0 Sell and 5 Hold. Therefore 76% are positive. JD.com had 42 analyst reports since August 4, 2015 according to SRatingsIntel. The stock of JD.com, Inc. (NASDAQ:JD) has “Buy” rating given on Thursday, August 11 by Nomura. The stock has “Neutral” rating by Credit Suisse on Tuesday, May 10. As per Thursday, August 6, the company rating was initiated by TH Capital. The firm earned “Buy” rating on Wednesday, August 23 by M Partners. The stock has “Underperform” rating by Bernstein on Wednesday, January 11. Bank of America maintained the shares of JD in report on Thursday, August 11 with “Neutral” rating. The firm earned “Buy” rating on Friday, October 14 by Stifel Nicolaus. The rating was upgraded by Nomura on Friday, January 22 to “Buy”. The stock of JD.com, Inc. (NASDAQ:JD) has “Buy” rating given on Monday, November 13 by KeyBanc Capital Markets. KeyBanc Capital Markets maintained JD.com, Inc. (NASDAQ:JD) on Thursday, October 19 with “Buy” rating.

Investors sentiment increased to 2.32 in 2017 Q2. Its up 0.66, from 1.66 in 2017Q1. It is positive, as 6 investors sold Genomic Health, Inc. shares while 32 reduced holdings. 11 funds opened positions while 52 raised stakes. 30.55 million shares or 1.09% more from 30.22 million shares in 2017Q1 were reported. Independent Port Consultants reported 15,951 shares. 131,935 were accumulated by Motley Fool Asset Limited Liability Com. Strs Ohio holds 0% or 22,500 shares. Bogle Investment Management L P De stated it has 0.14% in Genomic Health, Inc. (NASDAQ:GHDX). Dubuque Commercial Bank And Tru Company reported 4,897 shares or 0.03% of all its holdings. Jacobs Levy Equity holds 102,980 shares. 2.45M were reported by Blackrock. Macquarie Gru Ltd has invested 0% in Genomic Health, Inc. (NASDAQ:GHDX). Ny State Common Retirement Fund holds 20,900 shares. 565,324 are owned by Loomis Sayles L P. Legal & General Grp Inc Public Limited Liability Co reported 6,932 shares or 0% of all its holdings. Credit Suisse Ag accumulated 19,774 shares or 0% of the stock. California State Teachers Retirement System reported 35,020 shares. 927 are held by Great West Life Assurance Can. Spark Inv Mngmt Lc holds 172,600 shares or 0.35% of its portfolio.

The stock increased 20.50% or $5.74 during the last trading session, reaching $33.74. About 860,180 shares traded or 573.68% up from the average. Genomic Health, Inc. (NASDAQ:GHDX) has risen 23.46% since December 14, 2016 and is uptrending. It has outperformed by 6.76% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.